By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Securities and Exchange Commission today said that it has charged a former executive of Sequenom with making false statements to investors about the firm's prenatal test for Down syndrome.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.